These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28466289)

  • 1. [Personalised pharmacotherapy in intensive care unit patients].
    Bellmann R
    Med Klin Intensivmed Notfmed; 2017 May; 112(4):289-294. PubMed ID: 28466289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
    Landersdorfer CB; Nation RL
    Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
    Roberts JA; Lipman J
    Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?
    Dhont E; Van Der Heggen T; De Jaeger A; Vande Walle J; De Paepe P; De Cock PA
    Pediatr Nephrol; 2020 Jan; 35(1):25-39. PubMed ID: 30374606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment].
    Bellmann R
    Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):162-6. PubMed ID: 24643839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Jamal JA; Udy AA; Lipman J; Roberts JA
    Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
    Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics in the critically ill child.
    Zuppa AF; Barrett JS
    Pediatr Clin North Am; 2008 Jun; 55(3):735-55, xii. PubMed ID: 18501763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic dosing in critically ill patients with acute kidney injury.
    Eyler RF; Mueller BA;
    Nat Rev Nephrol; 2011 Apr; 7(4):226-35. PubMed ID: 21343897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill.
    Tsai D; Lipman J; Roberts JA
    Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
    Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of linezolid in critically ill patients.
    Sazdanovic P; Jankovic SM; Kostic M; Dimitrijevic A; Stefanovic S
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):595-600. PubMed ID: 27020789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adequate anti-infective treatment : Importance of individual dosing and application].
    Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR
    Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic dose optimization in critically ill patients.
    Cotta MO; Roberts JA; Lipman J
    Med Intensiva; 2015 Dec; 39(9):563-72. PubMed ID: 26415688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drugs dosing in intensive care unit during continuous renal replacement therapy].
    Bourquin V; Ponte B; Saudan P; Martin PY
    Nephrol Ther; 2009 Nov; 5(6):533-41. PubMed ID: 19369134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients.
    Heffernan AJ; Mohd Sazlly Lim S; Lipman J; Roberts JA
    Anaesth Crit Care Pain Med; 2021 Dec; 40(6):100970. PubMed ID: 34728411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose modulation: a new concept of antibiotic therapy in the critically ill patient?
    Goncalves-Pereira J; Paiva JA
    J Crit Care; 2013 Aug; 28(4):341-6. PubMed ID: 23337485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.
    Roberts DJ; Hall RI
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1067-84. PubMed ID: 23682923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing of antibiotics in critically ill patients undergoing renal replacement therapy.
    Kielstein JT; Burkhardt O
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2015-9. PubMed ID: 21554216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients.
    Fiore M; Peluso L; Taccone FS; Hites M
    Expert Opin Drug Metab Toxicol; 2021 May; 17(5):543-554. PubMed ID: 33733979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.